Central Nervous System Neoplasm (DBCOND0055396)

Identifiers

Synonyms
Central Nervous System Tumors / Central Nervous System Neoplasms / CNS neoplasm / CNS Tumor / Central Nervous System Tumor / Nervous System Tumor / CNS Tumours / CNS Neoplasms / Central Nervous System Tumour / CNS Tumors / Nervous System Tumors / Central nervous system tumours / Tumors of the Central Nervous System / Central nervous system neoplasm / CNS neoplasia / Neoplasm of central nervous system (disorder) / Neoplasm CNS / Central nervous system neoplasm NOS / CNS neoplasm NOS / Nervous system neoplasm / Nervous System Neoplasms / Nervous system neoplasm NOS / Neoplasm of nervous system (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT00003203
Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal TumorsNo drug interventionstreatment2completed
NCT00477503
Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPANo drug interventionstreatment1terminated
NCT00031590
Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed MedulloblastomaNo drug interventionstreatment2terminated
NCT01985451
Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma (PCNSL)treatment2unknown_status
NCT00109798
Temozolomide and Topotecan in Treating Patients With Primary CNS LymphomatreatmentNot Availablewithdrawn
NCT00040911
Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin LymphomaNo drug interventionssupportive_careNot Availablecompleted
NCT00107471
Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Gliomatreatment1 / 2terminated
NCT05308407
POWER UP: Participating Online While Exercising to Recover Using PlayNo drug interventionssupportive_careNot Availablesuspended
NCT00899834
DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem GliomaNo drug interventionsNot AvailableNot Availablecompleted
NCT00400816
Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytomatreatment2completed
NCT01067196
Outcomes Study of Late Effects After Proton RT for Pediatric Tumors of the Brain, Head, and NeckNo drug interventionsNot AvailableNot Availablecompleted
NCT00003096
Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT04351035
National Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China -- the CNOG-MC001 RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT00003935
Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Gliomatreatment1completed
NCT00003625
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Gliomatreatment1completed
NCT00187226
A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side EffectsNo drug interventionstreatment2completed
NCT05235074
OH2 Oncolytic Viral Therapy in Central Nervous System Tumorstreatment1 / 2recruiting
NCT00002944
Combination Chemotherapy in Treating Children With Progressive Brain TumorsNo drug interventionstreatment3completed
NCT00005812
Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or LymphomaNo drug interventionstreatment2terminated
NCT00607984
Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid TumorsNo drug interventionstreatmentNot Availableunknown_status
NCT00407433
Clinical Studies of Gemcitabine-OxaliplatinNo drug interventionstreatment2completed
NCT01735747
Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS LymphomaNo drug interventionstreatment2unknown_status
NCT00935545
Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS TumorsNo drug interventionstreatment1completed
NCT00945828
Assessing the Effectiveness of Individual Education Plans for Childhood Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT00876993
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) TumorsNo drug interventionstreatment1completed
NCT00002875
Radiation Therapy Plus Combination Chemotherapy in Treating Children With MedulloblastomaNo drug interventionstreatment3completed
NCT00003141
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord TumorsNo drug interventionstreatment1completed
NCT01135563
Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS TumoursNo drug interventionstreatment1completed
NCT01052363
OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade GliomasNo drug interventionstreatment1withdrawn
NCT00066248
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer TreatmentNo drug interventionssupportive_care2completed
NCT00152126
Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and LymphomasNo drug interventionstreatmentNot Availablecompleted
NCT02793466
Durvalumab in Pediatric and Adolescent PatientsNo drug interventionstreatment1completed
NCT00047320
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell TumorsNo drug interventionstreatment2completed
NCT00003573
Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced MedulloblastomaNo drug interventionstreatment2completed
NCT05081180
Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS TumorsNo drug interventionstreatment1recruiting
NCT02462629
Study of BLZ-100 in Pediatric Subjects With CNS TumorsNo drug interventionsother1completed
NCT01164189
Bevacizumab in Recurrent Grade II and III GliomaNo drug interventionstreatment2completed
NCT03050450
Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS TumorsNo drug interventionstreatment1terminated
NCT04859543
Pediatric Prospective Personalized Immune and Target Identification TrialNo drug interventionsdiagnosticNot Availablerecruiting
NCT00629187
Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancytreatment1terminated
NCT03188354
Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System LymphomaNo drug interventionsdiagnosticNot Availablecompleted
NCT02095353
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor PatientsNo drug interventionsNot AvailableNot Availableterminated
NCT02692898
Biomarker Analysis of Central Nervous System TumorsNo drug interventionsNot AvailableNot Availableterminated
NCT01931098
Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumabtreatment2completed
NCT00822432
Coproporphyrine Isomers and Methotrexate EliminationNo drug interventionsNot AvailableNot Availablecompleted
NCT01582152
Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastomatreatment1 / 2terminated
NCT04096716
Mapping Draining Lymph Nodes in CNS Malignanciesdiagnostic1terminated
NCT00185848
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid ArthritisNo drug interventionsdiagnostic1completed
NCT03257631
A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumorstreatment2completed
NCT03434262
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumorstreatment1completed
NCT03147989
Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS PatientsNot AvailableNot Availablecompleted
NCT04671368
Diagnostic Efficiency of Artificial Intelligence for Surgical NeuropathologyNo drug interventionsdiagnosticNot Availableunknown_status
NCT01180881
Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation TreatmentNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05835687
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS TumorsNo drug interventionstreatment1recruiting
NCT01579253
Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05850377
5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade GliomasNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03750188
Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrsNo drug interventionsNot AvailableNot Availablecompleted
NCT00328458
EPO906 Plus Radiation Therapy for the Treatment of Cancer PatientsNo drug interventionstreatment1completed
NCT02291822
Retrospective Study of MRI in Pediatric PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04541082
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsNo drug interventionstreatment1recruiting
NCT00329589
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer PatientsNo drug interventionstreatment1completed
NCT04525014
RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System TumorsNo drug interventionstreatment1terminated
NCT05386108
Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to ER+/HER-2- Breast CancerNo drug interventionstreatment1 / 2recruiting
NCT04023669
Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain TumorsNo drug interventionstreatment1active_not_recruiting
NCT05270707
HyperArc Registry StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05300113
Artificial Intelligence NeuropathologistNo drug interventionsNot AvailableNot Availablerecruiting
NCT04732065
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumorstreatment1recruiting
NCT05222165
Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterationstreatment1 / 2withdrawn
NCT04773782
A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signalingtreatment1 / 2recruiting
NCT06528691
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumorstreatment2recruiting
NCT05480904
Characterizing Sleep Among Long-term Survivors of Childhood CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05952687
Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid TumorsNo drug interventionstreatment1withdrawn
NCT03838042
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory MalignanciesNo drug interventionstreatment1 / 2recruiting
NCT06322342
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast AgentNo drug interventionsdiagnostic2recruiting
NCT04334239
Effectiveness of Care in Certified Cancer Centres in GermanyNo drug interventionsNot AvailableNot Availablecompleted
NCT02988726
Antineoplaston Therapy in Treating Patients With Neurofibroma and SchwannomaNo drug interventionstreatment2terminated
NCT06441331
Phase I Trial to Determine the Dose and Evaluate the PK of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive TumorsNo drug interventionstreatment1not_yet_recruiting
NCT04706676
Integrative Neuromuscular Training in Adolescents and Children Treated for CancerNo drug interventionspreventionNot Availablerecruiting
NCT06036394
Artificial Intelligence in CNS Radiation OncologyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05982691
Development of Asian Consortium for Data Collection and Clinical Trial of CNS TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02684838
Vigilant ObservatIon of GlIadeL WAfer ImplaNT RegistryNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00238264
Radiation Therapy in Treating Young Patients With GliomasNo drug interventionstreatment2completed
NCT03496402
Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)No drug interventionsotherNot Availablerecruiting
NCT04852354
Tissue Collection for Drug Screening and BioanalysisNo drug interventionsNot AvailableNot Availablerecruiting
NCT06104488
A Study of Avutometinib for People With Solid Tumor Cancerstreatment1recruiting
NCT00078988
High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomastreatment3completed
NCT00077207
Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade GliomatreatmentNot Availablecompleted
NCT00006024
Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Gliomatreatment1completed
NCT05978557
Brain Slice Explants to Predict Drug Response in Brain TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01595126
Longitudinal Study of BiomarkersNo drug interventionsNot AvailableNot Availableunknown_status
NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT02496520
Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young AdultsNo drug interventionstreatment1 / 2completed
NCT00716976
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancysupportive_care3completed
NCT06363201
Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid TumoursNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT00027846
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for EpendymomaNo drug interventionstreatment2completed
NCT06054295
Somatic Mosaicism in Twins Discordant for Childhood CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04185038
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System TumorsNo drug interventionstreatment1recruiting
NCT03052738
Medical Marijuana in the Pediatric Central Nervous System Tumor PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT00085098
Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell TumorNo drug interventionstreatment3completed
NCT02012699
Integrated Cancer Repository for Cancer ResearchNo drug interventionsNot AvailableNot Availablerecruiting
NCT03981016
Medical and Surgical Management of Patients With Brain MetastasesNo drug interventionsotherNot Availablecompleted
NCT00002594
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell TumorsNo drug interventionstreatment2completed
NCT02932280
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to TreatmentNo drug interventionstreatment1 / 2active_not_recruiting
NCT04743310
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas SystemNo drug interventionstreatment2recruiting
NCT05511714
Expanded Access [11C] Methionine PET ImagingNo drug interventionsNot AvailableNot Availableavailable
NCT05746104
Second Window Indocyanine Green for All Nervous System TumorsNo drug interventionsother1recruiting
NCT04516720
Creation of a Clinical Database on Primary Nervous System TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02687386
A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFRtreatment1terminated
NCT02221986
Interdisciplinary Rehabilitation of Patients With Glioma During Anti-cancer TreatmentNo drug interventionstreatmentNot Availablecompleted
NCT02797366
Proton Radiotherapy for Primary Central Nervous System Tumours in AdultsNo drug interventionstreatment2recruiting
NCT00100802
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed GliomasNo drug interventionstreatment2completed
NCT03834961
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemiatreatment2active_not_recruiting
NCT01217437
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumorstreatment2completed
NCT04692324
Cerebrospinal Fluid Biomarkers for Brain TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01941758
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumorsbasic_science1completed
NCT01474174
Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System TumorsNot AvailableNot Availablecompleted
NCT03012620
Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Typestreatment2completed
NCT01538095
Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System TumorsNo drug interventionstreatment1completed
NCT00898755
Collecting and Storing Tissue From Young Patients With CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05169151
Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA StudyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04988009
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-OncologyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03270059
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous SystemNo drug interventionsdiagnostic2recruiting
NCT03071913
Blood Brain Barrier Differences in Patients With Brain Tumors Undergoing SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT04539574
An Investigational Scan (7T MRI) for the Imaging of Central Nervous System TumorsNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT02867592
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare TumorsNo drug interventionstreatment2active_not_recruiting
NCT02402244
Project: Every Child for Younger Patients With CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02100891
Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumorstreatment2completed
NCT04081701
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.No drug interventionsdiagnostic4recruiting
NCT01505569
Auto Transplant for High Risk or Relapsed Solid or CNS TumorsNo drug interventionsotherNot Availablecompleted
NCT02650401
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsNo drug interventionstreatment1 / 2active_not_recruiting
NCT01032200
Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumorssupportive_care2completed
NCT05641636
Cardiovascular Disorders and Risk Factors in Childhood Cranial and Craniospinal Tumors SurvivorsNo drug interventionsNot AvailableNot Availablecompleted
NCT00633958
A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) TumorsNo drug interventionsdiagnostic1terminated
NCT03332030
Stem Cells in NF1 Patients With Tumors of the Central Nervous SystemNo drug interventionsNot AvailableNot Availablewithdrawn